Startups pursuing decarbonisation and energy-efficient technologies for heavy industry are the target of a new green investment fund set up by a top venture capital group with backing from the...
Monash University spinout Rage Biotech on Thursday announced a $29 million Series A raise to advance development of an inhaled RNA therapy for chronic inflammatory lung disease. The company...